Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer

Kevin M. Lin, M. Shashidharan, Alan G. Thorson, Charles A. Ternent, Garnet J. Blatchford, Mark A. Christensen, Patrice Watson, Stephen J. Lemon, Barbara Franklin, Beth Karr, Jane Lynch, Henry T. Lynch

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

The extracolonic tumor spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) includes cancer of the endometrium, ovaries, stomach, biliary tract, and urinary tract. This study was designed to determine the penetrance of colorectal and extracolonic tumors in HNPCC mutation carriers. Forty-nine patients (22 females and 27 males) were identified with an MSH2 germline mutation, and 56 patients (28 females and 28 males) were identified with an MLH1 mutation. Cumulative incidence by age 60 (lifetime risk) and mean age of cancer diagnosis were compared. The lifetime risk of extracolonic cancers in MSH2 and MLH1 carriers was 48% and 11% respectively (P = 0.016). Extracolonic cancer risk in MSH2 females and males was 69% and 34%, respectively (P = 0.042). Mean age of extracolonic cancer diagnosis was significantly older for MSH2 males than females (55.4 vs. 39.0, P = 0.013). No difference was observed in colorectal cancer risk between MLH1 and MSH2 carriers (84% vs. 71%). Colorectal cancer risk was 96% in MSH2 males compared to 39% in MSH2 females (P = 0.034). No differences in colorectal and extracolonic cancer risks between MLH1 females and males were identified. The risk of extracolonic cancer by age 60 was greater in MSH2 mutation carriers than in MLH1 carriers. Gender differences in colorectal and extracolonic cancer risk were observed for MSH2 carriers only. These phenotypic features of HNPCC genotypes may have clinical significance in the design of genotype-specific screening, surveillance, and follow-up for affected individuals.

Original languageEnglish
Pages (from-to)67-71
Number of pages5
JournalJournal of Gastrointestinal Surgery
Volume2
Issue number1
StatePublished - Jan 1998

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Colorectal Neoplasms
Mutation
Incidence
Neoplasms
Genotype
Penetrance
Germ-Line Mutation
Biliary Tract
Endometrial Neoplasms
Urinary Tract
Ovarian Neoplasms
Stomach

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer. / Lin, Kevin M.; Shashidharan, M.; Thorson, Alan G.; Ternent, Charles A.; Blatchford, Garnet J.; Christensen, Mark A.; Watson, Patrice; Lemon, Stephen J.; Franklin, Barbara; Karr, Beth; Lynch, Jane; Lynch, Henry T.

In: Journal of Gastrointestinal Surgery, Vol. 2, No. 1, 01.1998, p. 67-71.

Research output: Contribution to journalArticle

Lin, KM, Shashidharan, M, Thorson, AG, Ternent, CA, Blatchford, GJ, Christensen, MA, Watson, P, Lemon, SJ, Franklin, B, Karr, B, Lynch, J & Lynch, HT 1998, 'Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer', Journal of Gastrointestinal Surgery, vol. 2, no. 1, pp. 67-71.
Lin, Kevin M. ; Shashidharan, M. ; Thorson, Alan G. ; Ternent, Charles A. ; Blatchford, Garnet J. ; Christensen, Mark A. ; Watson, Patrice ; Lemon, Stephen J. ; Franklin, Barbara ; Karr, Beth ; Lynch, Jane ; Lynch, Henry T. / Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer. In: Journal of Gastrointestinal Surgery. 1998 ; Vol. 2, No. 1. pp. 67-71.
@article{edd0895a07714bd5811e4a6f44acdffb,
title = "Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer",
abstract = "The extracolonic tumor spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) includes cancer of the endometrium, ovaries, stomach, biliary tract, and urinary tract. This study was designed to determine the penetrance of colorectal and extracolonic tumors in HNPCC mutation carriers. Forty-nine patients (22 females and 27 males) were identified with an MSH2 germline mutation, and 56 patients (28 females and 28 males) were identified with an MLH1 mutation. Cumulative incidence by age 60 (lifetime risk) and mean age of cancer diagnosis were compared. The lifetime risk of extracolonic cancers in MSH2 and MLH1 carriers was 48{\%} and 11{\%} respectively (P = 0.016). Extracolonic cancer risk in MSH2 females and males was 69{\%} and 34{\%}, respectively (P = 0.042). Mean age of extracolonic cancer diagnosis was significantly older for MSH2 males than females (55.4 vs. 39.0, P = 0.013). No difference was observed in colorectal cancer risk between MLH1 and MSH2 carriers (84{\%} vs. 71{\%}). Colorectal cancer risk was 96{\%} in MSH2 males compared to 39{\%} in MSH2 females (P = 0.034). No differences in colorectal and extracolonic cancer risks between MLH1 females and males were identified. The risk of extracolonic cancer by age 60 was greater in MSH2 mutation carriers than in MLH1 carriers. Gender differences in colorectal and extracolonic cancer risk were observed for MSH2 carriers only. These phenotypic features of HNPCC genotypes may have clinical significance in the design of genotype-specific screening, surveillance, and follow-up for affected individuals.",
author = "Lin, {Kevin M.} and M. Shashidharan and Thorson, {Alan G.} and Ternent, {Charles A.} and Blatchford, {Garnet J.} and Christensen, {Mark A.} and Patrice Watson and Lemon, {Stephen J.} and Barbara Franklin and Beth Karr and Jane Lynch and Lynch, {Henry T.}",
year = "1998",
month = "1",
language = "English",
volume = "2",
pages = "67--71",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer

AU - Lin, Kevin M.

AU - Shashidharan, M.

AU - Thorson, Alan G.

AU - Ternent, Charles A.

AU - Blatchford, Garnet J.

AU - Christensen, Mark A.

AU - Watson, Patrice

AU - Lemon, Stephen J.

AU - Franklin, Barbara

AU - Karr, Beth

AU - Lynch, Jane

AU - Lynch, Henry T.

PY - 1998/1

Y1 - 1998/1

N2 - The extracolonic tumor spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) includes cancer of the endometrium, ovaries, stomach, biliary tract, and urinary tract. This study was designed to determine the penetrance of colorectal and extracolonic tumors in HNPCC mutation carriers. Forty-nine patients (22 females and 27 males) were identified with an MSH2 germline mutation, and 56 patients (28 females and 28 males) were identified with an MLH1 mutation. Cumulative incidence by age 60 (lifetime risk) and mean age of cancer diagnosis were compared. The lifetime risk of extracolonic cancers in MSH2 and MLH1 carriers was 48% and 11% respectively (P = 0.016). Extracolonic cancer risk in MSH2 females and males was 69% and 34%, respectively (P = 0.042). Mean age of extracolonic cancer diagnosis was significantly older for MSH2 males than females (55.4 vs. 39.0, P = 0.013). No difference was observed in colorectal cancer risk between MLH1 and MSH2 carriers (84% vs. 71%). Colorectal cancer risk was 96% in MSH2 males compared to 39% in MSH2 females (P = 0.034). No differences in colorectal and extracolonic cancer risks between MLH1 females and males were identified. The risk of extracolonic cancer by age 60 was greater in MSH2 mutation carriers than in MLH1 carriers. Gender differences in colorectal and extracolonic cancer risk were observed for MSH2 carriers only. These phenotypic features of HNPCC genotypes may have clinical significance in the design of genotype-specific screening, surveillance, and follow-up for affected individuals.

AB - The extracolonic tumor spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) includes cancer of the endometrium, ovaries, stomach, biliary tract, and urinary tract. This study was designed to determine the penetrance of colorectal and extracolonic tumors in HNPCC mutation carriers. Forty-nine patients (22 females and 27 males) were identified with an MSH2 germline mutation, and 56 patients (28 females and 28 males) were identified with an MLH1 mutation. Cumulative incidence by age 60 (lifetime risk) and mean age of cancer diagnosis were compared. The lifetime risk of extracolonic cancers in MSH2 and MLH1 carriers was 48% and 11% respectively (P = 0.016). Extracolonic cancer risk in MSH2 females and males was 69% and 34%, respectively (P = 0.042). Mean age of extracolonic cancer diagnosis was significantly older for MSH2 males than females (55.4 vs. 39.0, P = 0.013). No difference was observed in colorectal cancer risk between MLH1 and MSH2 carriers (84% vs. 71%). Colorectal cancer risk was 96% in MSH2 males compared to 39% in MSH2 females (P = 0.034). No differences in colorectal and extracolonic cancer risks between MLH1 females and males were identified. The risk of extracolonic cancer by age 60 was greater in MSH2 mutation carriers than in MLH1 carriers. Gender differences in colorectal and extracolonic cancer risk were observed for MSH2 carriers only. These phenotypic features of HNPCC genotypes may have clinical significance in the design of genotype-specific screening, surveillance, and follow-up for affected individuals.

UR - http://www.scopus.com/inward/record.url?scp=0032216468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032216468&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 67

EP - 71

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 1

ER -